Drug offers hope to neck and head cancer sufferers

New immunotherapy treatment twice as effective as chemotherapy against aggressive form of cancer

An immunotherapy drug could soon offer hope to patients with currently untreatable head and neck cancers.

Nivolumab was hailed a potential game-changer after it was found to extend the lives of relapsed patients who had run out of therapy options.